BioMarin Pharmaceutical Inc. buy Guggenheim
Start price
06.08.25
/
50%
€52.34
Target price
06.08.26
€91.63
Performance (%)
0.04%
Price
09:31
€52.36
Summary
This prediction is currently active. The BUY prediction by Guggenheim for BioMarin Pharmaceutical Inc. is nearly unchanged. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | 0.04% |
| iShares Core DAX® | -0.933% |
| iShares Nasdaq 100 | -2.152% |
| iShares Nikkei 225® | 0.021% |
| iShares S&P 500 | -2.296% |
Comments by Guggenheim for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Guggenheim from $101.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Guggenheim for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.26
13.09.23
13.09.23
€102.48
13.09.24
13.09.24
-11.56%
14.09.24
14.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€117.80
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24